Anvisa autoriza 5 novos medicamentos injetáveis à base de semaglutida

ONP 요약

Anvisa approved five new semaglutide-based injectable pens, known as "weight loss pens," for adults with type 2 diabetes and obesity, complementing diet and exercise. The decision was published in the official gazette on Wednesday.